Oxalobacter formigenes treatment combined with intensive dialysis lowers plasma oxalate and halts disease progression in a patient with severe infantile oxalosis

BACKGROUND: Infantile oxalosis, the most devastating form of primary hyperoxaluria type 1 (PH1), often leads to end-stage renal disease (ESRD) during the first weeks to months of life. CASE-DIAGNOSIS: Here, we report the outcome of the therapeutic use of Oxalobacter formigenes (Oxabact OC5; OxThera...

Descripción completa

Detalles Bibliográficos
Autores principales: Pape, Lars, Ahlenstiel-Grunow, Thurid, Birtel, Johannes, Krohne, Tim U., Hoppe, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184045/
https://www.ncbi.nlm.nih.gov/pubmed/32107618
http://dx.doi.org/10.1007/s00467-019-04463-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184045/
https://www.ncbi.nlm.nih.gov/pubmed/32107618
http://dx.doi.org/10.1007/s00467-019-04463-9

Ejemplares similares